Isomorphic Labs, an Alphabet-backed AI biotech firm, raised $600M to boost its AI drug design engine, expand clinical ...

AlphaFold 3, the improved version of the model used by Isomorphic Labs’ drug design engine, debuted last May. It can predict ...

Isomorphic Labs raised $600 million in its first external funding round, led by Thrive Capital with participation from GV and ...

as well as Alphabet. Isomorphic's technology platform has already generated a number of AI models that are being applied to the discovery of new medicines, and it already counts Eli Lilly and ...

Isomorphic Labs was founded to apply artificial intelligence to drug discovery. The company is led by AI researcher Sir Demis Hassabis.

Isomorphic Labs, which uses artificial intelligence technologies for drug discovery, has raised $600 million in its first ...

Isomorphic Labs says it is advancing drug design programs across multiple therapeutic areas and drug modalities. These ...

UK-based AI-first development company Isomorphic Labs revealed that it has raised $600 Million in its first external funding round. The financing round is led by Thrive Capital, with participation ...

Alphabet spinoff SandboxAQ — an AI and quantum computing startup — added another $150 million to its Series E from the likes ...